Update on the in vitro activity of ceftaroline against Staphylococcus aureus from United States (US) medical centers stratified by infection type (2018-2020)

被引：4
|
作者：
Sader, Helio S. [1 ]
Castanheira, Mariana [1 ]
Duncan, Leonard R. [1 ]
Mendes, Rodrigo E. [1 ]
机构：
[1] JMI Labs, North Liberty, IA 52317 USA
来源：
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 2023年 / 105卷 / 01期
关键词：
MRSA; skin and skin structure infection; pneumonia; ceftaroline; Staphylococcus aureus; VANCOMYCIN;
D O I：
10.1016/j.diagmicrobio.2022.115820
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Ceftaroline and comparators were tested against 9,268 Staphylococcus aureus isolates from 33 United States hospitals (2018-2020). Ceftaroline (MIC50/90, 0.25/1 mg/L) susceptibility ranged from 95.4% (pneumonia) to 98.5% (skin and skin structure) and was 97.2% overall. Ceftaroline retained potent and broad-spectrum activ-ity against methicillin-resistant isolates, with a 93.4% overall susceptibility. (c) 2022 Published by Elsevier Inc.
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Activity of Ceftaroline and Epidemiologic Trends in Staphylococcus aureus Isolates Collected from 43 Medical Centers in the United States in 2009
    Richter, Sandra S.
    Heilmann, Kristopher P.
    Dohrn, Cassie L.
    Riahi, Fathollah
    Costello, Andrew J.
    Kroeger, Jennifer S.
    Biek, Donald
    Critchley, Ian A.
    Diekema, Daniel J.
    Doern, Gary V.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (09) : 4154 - 4160
  • [2] Antimicrobial Activity of Ceftaroline Tested against Staphylococcus aureus from Surgical Skin and Skin Structure Infections in US Medical Centers
    Sader, Helio S.
    Farrell, David J.
    Flamm, Robert K.
    Jones, Ronald N.
    SURGICAL INFECTIONS, 2016, 17 (04) : 443 - 447
  • [3] Antimicrobial activity of dalbavancin against Gram-positive bacteria isolated from patients hospitalized with bloodstream infection in United States and European medical centers (2018-2020)
    Sader, Helio S.
    Castanheira, Mariana
    Huband, Michael D.
    Shortridge, Dee
    Carvalhaes, Cecilia G.
    Mendes, Rodrigo M.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2022, 41 (05) : 867 - 873
  • [4] Ceftaroline Activity Against Mdr Streptococcus Pneumoniae Subsets From United States Medical Centers (2014)
    Farrell, D. J.
    Mendes, R. E.
    Flamm, R. K.
    Sader, H. S.
    Jones, R. N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [5] Comparative in-vitro activity of ceftaroline against Staphylococcus aureus isolates from India
    Bakthavatchalam, Yamuna Devi
    Pragasam, Agila Kumari
    Anandan, Shalini
    Joshi, Sangeeta
    Chaudhuri, Bhaskar Naryanan
    Chitnis, D. S.
    Roy, Indranil
    Tapan, Dhole
    Veeraraghavan, Balaji
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2016, 10 (01): : 109 - 112
  • [6] In Vitro Activity of Vancomycin, Teicoplanin, Linezolid and Daptomycin Against Methicillin- Resistant Staphylococcus aureus Isolates Collected from Chinese Hospitals in 2018-2020
    Xu, Yanlei
    Wang, Bingjie
    Zhao, Huilin
    Wang, Xinyi
    Rao, Lulin
    Ai, Wenxiu
    Yu, Jingyi
    Guo, Yinjuan
    Wu, Xiaocui
    Yu, Fangyou
    Chen, Shuying
    INFECTION AND DRUG RESISTANCE, 2021, 14 : 5449 - 5456
  • [7] Ceftaroline Activity Against Bacterial Isolates from Patients with Community-Acquired Respiratory Tract Infections from United States Medical Centers in 2009, Including Methicillin-Resistant Staphylococcus aureus
    Sader, H. S.
    Farrell, D. J.
    Jones, R. N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [8] Antimicrobial Activity of Dalbavancin against Staphylococcus aureus with Decreased Susceptibility to Glycopeptides, Daptomycin, and/or Linezolid from US Medical Centers
    Sader, Helio S.
    Mendes, Rodrigo E.
    Duncan, Leonard R.
    Pfaller, Michael A.
    Flamm, Robert K.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (03)
  • [9] Antimicrobial activity of dalbavancin against Gram-positive bacteria isolated from patients hospitalized with bloodstream infection in United States and European medical centers (2018–2020)
    Helio S. Sader
    Mariana Castanheira
    Michael D. Huband
    Dee Shortridge
    Cecilia G. Carvalhaes
    Rodrigo M. Mendes
    European Journal of Clinical Microbiology & Infectious Diseases, 2022, 41 : 867 - 873
  • [10] Activity of ceftaroline and comparator agents tested against Staphylococcus aureus from patients with bloodstream infections in US medical centres (2009-13)
    Sader, Helio S.
    Farrell, David J.
    Flamm, Robert K.
    Jones, Ronald N.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (07) : 2053 - 2056
12345